Skip Navigation

European Journal of Heart Failure 2005 7(5):892-898; doi:10.1016/j.ejheart.2004.09.006
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Galve, E.
Right arrow Articles by Soler-Soler, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galve, E.
Right arrow Articles by Soler-Soler, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 European Society of Cardiology

Clinical and neurohumoral consequences of diuretic withdrawal in patients with chronic, stabilized heart failure and systolic dysfunction

Enrique Galve*,a, Anna Mallola, Robert Catalanb, Jordi Paleta, Stella Méndeza, Elsa Nietoa, Anna Diaza and Jordi Soler-Solera

a Servei de Cardiologia, Hospital General Universitari Vall d'Hebron Pg Vall d'Hebron 119-129, 08035 Barcelona, Spain
b Servei de Bioquímica Hospital General Universitari Vall d'Hebron, Barcelona, Spain

* Corresponding author. Tel.: +34 93 274 6134; fax: +34 93 274 6063. E-mial address: egalve{at}vhebron.net


   Abstract

Background: Loop diuretics are beneficial in heart failure in the short term because they eliminate fluid retention, but in the long-term, they could adversely influence prognosis due to activation of neurohumoral mechanisms.

Aims: To explore the changes induced by diuretic withdrawal in chronic nonadvanced heart failure.

Methods: Diuretics were withdrawn in 26 stabilized heart failure patients with systolic dysfunction (ejection fraction [EF]<45%). Clinical status was evaluated by physical exam, exercise capacity (corridor test) and New York Heart Association (NYHA) class. Biochemical and neurohumoral determinations were performed at baseline and at 3 months.

Results: At 3 months, 17 out of 26 patients (65%) were able to tolerate diuretic interruption without a deterioration in exercise capacity or New York Heart Association functional class. Renal function parameters improved (baseline urea 46.2±10.8 to 39.2±10.1 mg/dl at 3 months, p=0.014; creatinine 1.1±0.23 to 0.98±0.2 mg/dl, p=0.013). Glucose metabolism also improved (fasting glucose 151±91 to 122±14 mg/dl, p=0.035). Heart rate and systolic blood pressure did not significantly change, while diastolic blood pressure increased (from 80±10 to 87±13 mm Hg, p=0.006). Neurohumoral determinations showed a decrease in plasma renin activity (4.19±5.96 to 2.88±4.98 ng/ml, p=0.026), with no changes in aldosterone, arginine-vasopressin, endothelin-1 and norepinephrine. In contrast, atrial natriuretic peptide significantly increased (115±87 to 168±155 pg/ml, p=0.004).

Conclusion: Diuretic withdrawal in stabilized heart failure with systolic dysfunction is associated with an improvement in renal function parameters, glucose metabolism and some neurohumoral parameters, such as plasma renin activity; however, atrial natriuretic peptide levels increased.

Key Words: Heart failure • Diuretics • Neurohumoral activation

Received April 19, 2004; Revised September 14, 2004; Accepted September 20, 2004


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.